Activation of the ERK pathway is one of the key mechanisms for the initiation and progression in many human cancers including colorectal cancer [41], thus the decrease of pERK in HT-29 cells by both phytate and butyrate proves their anticancer activity. The gene discussed is MAPK1; the disease is cancer.